Morgan Stanley
PAVM icon

Morgan Stanley’s PAVmed PAVM Stock Holding History

Morgan Stanley’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.68K Buy
165
+4
+2% +$38 ﹤0.01% 7358
2025
Q4 		$1.07K Sell
161
-7
-4% -$80 ﹤0.01% 7350
2025
Q3 		$2.17K Hold
168
– – ﹤0.01% 7288
2025
Q2 		$3.02K Buy
168
+8
+5% +$160 ﹤0.01% 7146
2025
Q1 		$3.46K Hold
160
– – ﹤0.01% 7074
2024
Q4 		$3.01K Sell
160
-1
-0.6% -$30 ﹤0.01% 7117
2024
Q3 		$5.95K Sell
161
-8
-5% -$245 ﹤0.01% 6859
2024
Q2 		$4.13K Sell
169
-2
-1% -$100 ﹤0.01% 6898
2024
Q1 		$11K Sell
171
-1
-0.6% -$76 ﹤0.01% 6668
2023
Q4 		$21.3K Buy
172
+47
+38% +$5.54K ﹤0.01% 6639
2023
Q3 		$16.6K Sell
125
-53
-30% -$8.22K ﹤0.01% 6543
2023
Q2 		$32.7K Sell
178
-45
-20% -$9K ﹤0.01% 6374
2023
Q1 		$37.5K Sell
223
-73
-25% -$15.4K ﹤0.01% 6389
2022
Q4 		$64K Sell
296
-101
-25% -$38.1K ﹤0.01% 6183
2022
Q3 		$154K Sell
397
-147
-27% -$83.3K ﹤0.01% 5857
2022
Q2 		$229K Sell
544
-459
-46% -$222K ﹤0.01% 5829
2022
Q1 		$596K Sell
1,003
-1,485
-60% -$1.1M ﹤0.01% 5301
2021
Q4 		$2.75M Sell
2,488
-44
-2% -$95.6K ﹤0.01% 4311
2021
Q3 		$9.73M Buy
2,532
+829
+49% +$2.61M ﹤0.01% 2924
2021
Q2 		$4.91M Buy
1,703
+370
+28% +$874K ﹤0.01% 3797
2021
Q1 		$2.66M Buy
1,333
+434
+48% +$653K ﹤0.01% 4037
2020
Q4 		$857K Buy
899
+647
+257% +$553K ﹤0.01% 4755
2020
Q3 		$202K Sell
252
-1
-0.4% -$890 ﹤0.01% 5115
2020
Q2 		$240K Buy
253
+123
+95% +$123K ﹤0.01% 4988
2020
Q1 		$116K Buy
+130
New +$106K ﹤0.01% 5127
2018
Q4 		– Sell
-20
Closed -$12K – 6687
2018
Q3 		$12K Sell
20
-4
-17% -$2.44K ﹤0.01% 6272
2018
Q2 		$10K Hold
24
– – ﹤0.01% 6309
2018
Q1 		$18K Hold
24
– – ﹤0.01% 6150
2017
Q4 		$25K Buy
+24
New +$42.2K ﹤0.01% 6021

Other funds holding PAVM

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Morgan Stanley's PAVM Position: Q1 2026 in Review

Morgan Stanley increased its PAVmed (PAVM) stake by 2.5% in Q1 2026, buying an estimated $38 and bringing the position to 165 shares worth $1.68K. The position accounts for ﹤0.01% of the portfolio, ranked #7358.

Morgan Stanley first reported a position in PAVM in Q4 2017 and has held it in 29 quarters since. The position peaked at $9.73M in Q3 2021. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2026.

  • Morgan Stanley held 165 shares of PAVmed worth $1.68K as of Q1 2026.
  • Morgan Stanley bought 4 PAVmed shares in Q1 2026, an estimated $38.
  • PAVmed made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7358 holding.
  • Morgan Stanley first reported a position in PAVmed in Q4 2017 and has held it in 29 quarters since.
  • Morgan Stanley's PAVmed position peaked at $9.73M in Q3 2021.
  • 20 funds tracked by Wall St. Rank held PAVmed as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.